Atai life sciences to participate in the upcoming td cowen 44th annual health care conference

New york and berlin, feb. 28, 2024 (globe newswire) -- atai life sciences (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that management will participate in a panel discussion at the td cowen conference in boston, ma, at 12:50pm et on march 4, 2024.

ATAI Ratings Summary

ATAI Quant Ranking